Support product quality with specialized CMC expertise
Quality is a critical pillar of every medicine, alongside safety and efficacy. From early development through commercialization and lifecycle management, CMC activities support the quality, consistency, and compliance needed to bring products to patients.
Cencora combines CMC strategy, scientific and technical expertise, authoring, compliance, and digital readiness to help companies navigate evolving requirements and maintain quality throughout the product lifecycle.
Cencora combines CMC strategy, scientific and technical expertise, authoring, compliance, and digital readiness to help companies navigate evolving requirements and maintain quality throughout the product lifecycle.
Overcome the biggest CMC challenges for small molecules
CMC requirements for small molecules are complex, evolving, and resource-intensive. Expert support across the lifecycle helps you address what most often slows approvals, raises compliance risk, and strains internal teams.
Regulatory complexity
CMC requirements differ across regions and product types and keep evolving. Meeting them consistently across global markets takes specialized, up-to-date expertise.
Complex manufacturing networks
Mergers, acquisitions, technology transfers, and growing manufacturing networks make it harder to keep processes robust and interfaces aligned.
Compliance risk
Gaps in CMC documentation and change management can lead to approval delays, health authority questions, corrective actions, recalls, or loss of marketing authorization.
Complete CMC coverage from early development to post-approval
Our CMC experts support your small molecule programs from early development through dossier submission and post-approval lifecycle management, across global markets.
Cencora provides strategic consulting, scientific and technical writing, and compliance and lifecycle support, including readiness for International Council for Harmonisation (ICH) M4Q(R2).
What we offer
Strategy and consulting
Regulatory intelligence and quality guidance from early development through lifecycle management, covering pathway selection, risk assessments, and global registration strategy.
Dossier authoring and review
Preparation, review, and compilation of quality sections for clinical and marketing applications, active substance and drug master files, and certificates of suitability.
Scientific and technical writing
Expert reports, impurity and nitrosamine evaluations, stability assessments, process validation, analytical documentation, and health authority briefing materials.
Change control and variations
Manufacturing change management from impact assessment and gap analysis through submission-ready documentation, regulatory implementation, site transfers, and market expansion.
Compliance and remediation
CMC gap analysis, remediation planning, and support for health authority commitments and inspection-related CMC documentation.
Health authority engagement
Expert support for scientific advice meetings, agency interactions, and deficiency responses, from early preparation through to written follow-up.
Why choose Cencora for CMC small molecule
Global expert network
Regulatory and CMC specialists in every market where you file, giving you local expertise wherever your program operates.
Integrated program support
Connected support across CMC, writing, publishing, quality, and lifecycle management, keeping delivery consistent between phases and markets.
Future-ready quality content
Future-ready CMC support covering evolving quality dossier standards, structured content, and digital authoring approaches, including readiness for ICH M4Q(R2).
Expert insight
Manufacturing site transfers are rarely standalone changes. Rather, they commonly comprise multiple regulatory variations of varying complexity that are reviewed differently by health authorities around the world.
— Nelli Ziegler
Manufacturing site transfers in a volatile world: Pain points, regulatory challenges, and strategic imperatives
Related solutions
CMC services
Get end-to-end Chemistry, Manufacturing, and Controls (CMC) support across product types, from early development through registration and post-approval lifecycle management.
Regulatory lifecycle management and maintenance activities
Keep approved products compliant and available after launch with variations, renewals, labeling, and post-approval maintenance in the markets you serve.
PharmaLex is now Cencora
CMC small molecule is part of our Commercialization support capability. Same team, same expertise, now with greater reach.
Need more information about CMC small molecule?
Our team of experts is here to assist you. Whether you have questions or need more detailed information, don’t hesitate to get in touch. We’re dedicated to providing the support you need.